天疱疮并发自身免疫性甲状腺疾病影响因素的研究进展
Research Progress on the Influencing Factors of Pemphigus Complicated with Autoimmune Thyroid Disease
DOI: 10.12677/acm.2026.1641231, PDF,   
作者: 许银德, 李晓岚*:昆明医科大学第二附属医院皮肤性病科,云南 昆明
关键词: 天疱疮自身免疫性甲状腺疾病影响因素Pemphigus Autoimmune Thyroid Disease Influencing Factors
摘要: 天疱疮作为自身抗体介导的自身免疫性大疱性疾病,除皮肤与黏膜受累外,越来越多证据提示其可与其他自身免疫病呈聚集或共病现象。自身免疫性甲状腺疾病(AITD)是最常见的器官特异性自身免疫病之一,部分研究显示天疱疮患者甲状腺功能异常及甲状腺自身抗体阳性率升高,提示二者可能共享一定的免疫遗传背景与触发因素。现有证据认为,遗传易感、环境暴露、免疫调控失衡以及性激素差异,可能在天疱疮并发AITD的发生具有协同作用,临床治疗因素对天疱疮和AITD也具有潜在影响。本文围绕上述影响因素作一综述,以期对两者共病机制阐释和临床风险识别提供参考。
Abstract: Pemphigus is an autoantibody-mediated autoimmune blistering disease that primarily affects the skin and mucous membranes. Increasing evidence suggests that pemphigus is frequently associated with other autoimmune disorders, reflecting a tendency toward autoimmune clustering or comorbidity. Autoimmune thyroid disease (AITD) is one of the most common organ-specific autoimmune diseases. Several studies have reported a higher prevalence of thyroid dysfunction and thyroid autoantibody positivity in patients with pemphigus, suggesting that the two conditions may share common immunogenetic backgrounds and triggering factors. Current evidence indicates that genetic susceptibility, environmental exposure, immune dysregulation, and sex hormone differences may act synergistically in the development of pemphigus complicated with AITD. In addition, therapeutic factors used in clinical practice may also exert potential effects on both pemphigus and AITD. This review summarizes the above influencing factors, aiming to provide insights into the mechanisms underlying their comorbidity and to improve clinical risk identification.
文章引用:许银德, 李晓岚. 天疱疮并发自身免疫性甲状腺疾病影响因素的研究进展[J]. 临床医学进展, 2026, 16(4): 110-119. https://doi.org/10.12677/acm.2026.1641231

参考文献

[1] Porro, A.M., Seque, C.A., Ferreira, M.C.C. and Enokihara, M.M.S.E.S. (2019) Pemphigus vulgaris. Anais Brasileiros de Dermatologia, 94, 264-278. [Google Scholar] [CrossRef] [PubMed]
[2] Spindler, V., Eming, R., Schmidt, E., Amagai, M., Grando, S., Jonkman, M.F., et al. (2018) Mechanisms Causing Loss of Keratinocyte Cohesion in Pemphigus. Journal of Investigative Dermatology, 138, 32-37. [Google Scholar] [CrossRef] [PubMed]
[3] Bardazzi, F., Rucci, P., Rosa, S., Loi, C., Iommi, M. and Altobrando, A.D. (2021) Comorbid Diseases Associated with Pemphigus: A Case‐Control Study. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 19, 1613-1619. [Google Scholar] [CrossRef] [PubMed]
[4] Lee, H.J., Li, C.W., Hammerstad, S.S., Stefan, M. and Tomer, Y. (2015) Immunogenetics of Autoimmune Thyroid Diseases: A Comprehensive Review. Journal of Autoimmunity, 64, 82-90. [Google Scholar] [CrossRef] [PubMed]
[5] Leshem, Y.A., Katzenelson, V., Yosipovitch, G., David, M. and Mimouni, D. (2011) Autoimmune Diseases in Patients with Pemphigus and Their First‐Degree Relatives. International Journal of Dermatology, 50, 827-831. [Google Scholar] [CrossRef] [PubMed]
[6] Zeng, L., Huang, X., Yao, Y. and Zhang, G. (2023) Pemphigus and Thyroid Disease: A Systematic Review and Meta-Analysis. European Journal of Inflammation, 21. [Google Scholar] [CrossRef
[7] Kridin, K., Hübner, F., Linder, R. and Schmidt, E. (2022) The Association of Six Autoimmune Bullous Diseases with Thyroid Disorders: A Population‐Based Study. Journal of the European Academy of Dermatology and Venereology, 36, 1826-1830. [Google Scholar] [CrossRef] [PubMed]
[8] Wang, H., Yang, Y., Hu, J., Zhang, L., Cai, Y., Guo, H., et al. (2021) Serum Detection of Anti-Thyroid Peroxidase and Anti-Thyroglobulin Antibodies in Chinese Patients with Pemphigus Vulgaris and Pemphigus Foliaceus and Literature Review. Frontiers in Immunology, 12, Article 653356. [Google Scholar] [CrossRef] [PubMed]
[9] Seiffert-Sinha, K., Khan, S., Attwood, K., Gerlach, J.A. and Sinha, A.A. (2018) Anti-Thyroid Peroxidase Reactivity Is Heightened in Pemphigus Vulgaris and Is Driven by Human Leukocyte Antigen Status and the Absence of Desmoglein Reactivity. Frontiers in Immunology, 9, Article 625. [Google Scholar] [CrossRef] [PubMed]
[10] Yan, L., Wang, J. and Zeng, K. (2012) Association between HLA‐DRB1 Polymorphisms and Pemphigus Vulgaris: A Meta‐Analysis. British Journal of Dermatology, 167, 768-777. [Google Scholar] [CrossRef] [PubMed]
[11] Vodo, D., Sarig, O. and Sprecher, E. (2018) The Genetics of Pemphigus Vulgaris. Frontiers in Medicine, 5, Article 226. [Google Scholar] [CrossRef] [PubMed]
[12] Simmonds, M.J. (2013) GWAS in Autoimmune Thyroid Disease: Redefining Our Understanding of Pathogenesis. Nature Reviews Endocrinology, 9, 277-287. [Google Scholar] [CrossRef] [PubMed]
[13] Zhao, R., Zhang, W., Ma, C., Zhao, Y., Xiong, R., Wang, H., et al. (2021) Immunomodulatory Function of Vitamin D and Its Role in Autoimmune Thyroid Disease. Frontiers in Immunology, 12, Article 574967. [Google Scholar] [CrossRef] [PubMed]
[14] Vrysis, C., Beneki, E., Zintzaras, E. and Doxani, C. (2022) Assessment of the Reporting Quality of Randomised Controlled Trials for Vitamin D Supplementation in Autoimmune Thyroid Disorders Based on the CONSORT Statement. Endocrine, 80, 346-354. [Google Scholar] [CrossRef] [PubMed]
[15] Moravvej, H., Mozafari, N. and Younespour, S. (2015) Serum 25-Hydroxy Vitamin D Level in Patients with Pemphigus and Its Association with Disease Severity. Clinical and Experimental Dermatology, 41, 142-147. [Google Scholar] [CrossRef] [PubMed]
[16] Khozam, S.A., Sumaili, A.M., Alflan, M.A. and Shawabkeh, R.A.S. (2022) Association between Vitamin D Deficiency and Autoimmune Thyroid Disorder: A Systematic Review. Cureus, 14, e25869. [Google Scholar] [CrossRef] [PubMed]
[17] Chao, G., Zhu, Y. and Fang, L. (2020) Correlation between Hashimoto’s Thyroiditis-Related Thyroid Hormone Levels and 25-Hydroxyvitamin D. Frontiers in Endocrinology, 11, Article 4. [Google Scholar] [CrossRef] [PubMed]
[18] Rattanamusik, N., Uitrakul, S. and Charoenpiriya, A. (2023) Vitamin D Levels in Patients with Active and Remission Graves’ Disease. Medicines, 10, Article 41. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, H., Liang, L. and Xie, Z. (2015) Low Vitamin D Status Is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. Endocrine Practice, 21, 258-263. [Google Scholar] [CrossRef] [PubMed]
[20] Rübben, A. (2020) Anale Herpes-Simplex-Virus-Infektionen. Der Hautarzt, 71, 293-297. [Google Scholar] [CrossRef] [PubMed]
[21] 张寒梅, 冯素英. 天疱疮合并单纯疱疹病毒感染的研究进展[J]. 中华皮肤科杂志, 2022, 55(6): 545-548.
[22] Vega-Memíje, M.E., García-Vázquez, F.J., Cuevas-González, J.C., Rodríguez-Lobato, E. and Aguilar-Urbano, M.A. (2015) Is There a Causal Relationship between HSV-1 and Pemphigus Vulgaris? SpringerPlus, 4, Article No. 811. [Google Scholar] [CrossRef] [PubMed]
[23] Baum, S., Atar, I., Coster, D., Dovrat, S., Solomon, M., Sprecher, E., et al. (2022) Relationship between Pemphigus Vulgaris Severity and Pcr-Positive Herpes Simplex Virus. Acta Dermato-Venereologica, 102, adv00703. [Google Scholar] [CrossRef] [PubMed]
[24] Mori, K. and Yoshida, K. (2010) Viral Infection in Induction of Hashimotoʼs Thyroiditis: A Key Player or Just a Bystander? Current Opinion in Endocrinology, Diabetes and Obesity, 17, 418-424. [Google Scholar] [CrossRef] [PubMed]
[25] Caselli, E., Zatelli, M.C., Rizzo, R., Benedetti, S., Martorelli, D., Trasforini, G., et al. (2012) Virologic and Immunologic Evidence Supporting an Association between HHV-6 and Hashimoto’s Thyroiditis. PLOS Pathogens, 8, e1002951. [Google Scholar] [CrossRef] [PubMed]
[26] Li, S., Wu, Q., Fan, Y., Guo, F., Hu, X. and Zuo, Y. (2024) Gut Microbiome Dysbiosis in Patients with Pemphigus and Correlation with Pathogenic Autoantibodies. Biomolecules, 14, Article 880. [Google Scholar] [CrossRef] [PubMed]
[27] Yan, K., Sun, X., Fan, C., Wang, X. and Yu, H. (2024) Unveiling the Role of Gut Microbiota and Metabolites in Autoimmune Thyroid Diseases: Emerging Perspectives. International Journal of Molecular Sciences, 25, Article 10918. [Google Scholar] [CrossRef] [PubMed]
[28] Fang, Y., Zhang, X., Huang, R., Liu, J. and Li, Z. (2024) Gut Microbiota and Autoimmune Thyroid Disease: A Bidirectional Mendelian Randomization Study and Mediation Analysis. Frontiers in Microbiology, 15, Article 1443643. [Google Scholar] [CrossRef] [PubMed]
[29] Ruocco, V., Ruocco, E., Lo Schiavo, A., Brunetti, G., Guerrera, L.P. and Wolf, R. (2013) Pemphigus: Etiology, Pathogenesis, and Inducing or Triggering Factors: Facts and Controversies. Clinics in Dermatology, 31, 374-381. [Google Scholar] [CrossRef] [PubMed]
[30] Lai, O., Recke, A., Zillikens, D. and Kasperkiewicz, M. (2018) Influence of Cigarette Smoking on Pemphigus—A Systematic Review and Pooled Analysis of the Literature. Journal of the European Academy of Dermatology and Venereology, 32, 1256-1262. [Google Scholar] [CrossRef] [PubMed]
[31] Ferrari, S.M., Fallahi, P., Antonelli, A. and Benvenga, S. (2017) Environmental Issues in Thyroid Diseases. Frontiers in Endocrinology, 8, Article 50. [Google Scholar] [CrossRef] [PubMed]
[32] Sawicka-Gutaj, N., Gutaj, P., Sowiński, J., Wender-Ożegowska, E., Czarnywojtek, A., Brązert, J., et al. (2014) Wpływ palenia papierosów na tarczycę—Aktualizacja. Endokrynologia Polska, 65, 54-62. [Google Scholar] [CrossRef] [PubMed]
[33] Khantakova, J.N. and Sennikov, S.V. (2023) T-Helper Cells Flexibility: The Possibility of Reprogramming T Cells Fate. Frontiers in Immunology, 14, Article 1284178. [Google Scholar] [CrossRef] [PubMed]
[34] Araghi, F., Dadkhahfar, S., Robati, R.M., Tabary, M. and Shahidi-Dadras, M. (2022) The Emerging Role of T Cells in Pemphigus Vulgaris: A Systematic Review. Clinical and Experimental Medicine, 23, 1045-1054. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, Q., Cui, F., Wang, M., Xiong, H., Peng, X., Liang, L., et al. (2018) Increased Expression of MicroRNA-338-3p Contributes to Production of Dsg3 Antibody in Pemphigus Vulgaris Patients. Molecular Medicine Reports, 18, 550-556. [Google Scholar] [CrossRef] [PubMed]
[36] Bogusławska, J., Godlewska, M., Gajda, E. and Piekiełko-Witkowska, A. (2022) Cellular and Molecular Basis of Thyroid Autoimmunity. European Thyroid Journal, 11, Article ID: e210024. [Google Scholar] [CrossRef] [PubMed]
[37] Esfahanian, F., Naimi, E., Doroodgar, F. and Jadali, Z. (2013) Th1/Th2 Cytokines in Patients with Graves’ Disease with or without Ophthalmopathy. Iranian Journal of Allergy, Asthma and Immunology, 12, 168-175.
[38] Vargas-Uricoechea, H. (2023) Molecular Mechanisms in Autoimmune Thyroid Disease. Cells, 12, Article 918. [Google Scholar] [CrossRef] [PubMed]
[39] Xu, R., Zhu, H., Li, W., Zhao, X., Yuan, H., Zheng, J., et al. (2013) The Imbalance of Th17 and Regulatory T Cells in Pemphigus Patients. European Journal of Dermatology, 23, 795-802. [Google Scholar] [CrossRef] [PubMed]
[40] He, H., Jiang, Y., Qiu, J., Shen, F., Qian, D. and Meng, L. (2025) Role of Interleukin 17 and T Helper Cells 17 Cells as a New Immune Target and Signalling in the Pathogenesis and Treatment of Autoimmune Thyroid Diseases. Annals of Medicine, 57, Article ID: 2586216. [Google Scholar] [CrossRef
[41] Wang, C., Zhang, H., Liu, T., Wang, Z., Zhang, Y., Yu, G., et al. (2023) Circulating Tfr/Tfh Cell Imbalance May Contribute to the Immunopathogenesis of Pemphigus. Journal of the European Academy of Dermatology and Venereology, 37, e1399-e1402. [Google Scholar] [CrossRef] [PubMed]
[42] Cai, Y., Wang, Z., Liu, X., Wei, L., Li, S., Zheng, X., et al. (2022) The Frequency of Intrathyroidal Follicular Helper T Cells Varies with the Progression of Graves’ Disease and Hashimoto’s Thyroiditis. Journal of Immunology Research, 2022, Article ID: 4075522. [Google Scholar] [CrossRef] [PubMed]
[43] Li, L., Shen, S., Shao, S., Dang, E., Wang, G., Fang, H., et al. (2025) The Role of B Cell-Activating Factor System in Autoimmune Diseases: Mechanisms, Disease Implications, and Therapeutic Advances. Frontiers in Immunology, 16, Article 1538555. [Google Scholar] [CrossRef] [PubMed]
[44] Wang, S., Liu, S., Li, S. and Zuo, Y. (2025) B-Cell-Activating Factor and a Proliferation-Inducing Ligand (BAFF/APRIL) Blockade with Telitacicept in Pemphigus Foliaceus: Two Cases. British Journal of Dermatology. [Google Scholar] [CrossRef
[45] Musledin, Ș., Circo, E. and Scrinic, O. (2025) B-Cell-Activating Factor (BAFF) Correlated with Serum Vitamin D Values—Possible Markers with a Prognostic Role in Thyroid Autoimmune Diseases. Journal of Clinical Medicine, 14, Article 3168. [Google Scholar] [CrossRef] [PubMed]
[46] 陈丽好, 张丽娟, 张艳昕, 等. 甲状腺过氧化物酶自身抗体在寻常型天疱疮与桥本甲状腺炎共病中的作用研究[J]. 中华口腔医学杂志, 2025, 60(2): 179-183.
[47] Janegova, A., Janega, P., Rychly, B., Kuracinova, K. and Babal, P. (2015) Rola infekcji wirusem Epstein-Barr’a w rozwoju autoimmunologicznych chorób tarczycy. Endokrynologia Polska, 66, 132-136. [Google Scholar] [CrossRef] [PubMed]
[48] Chernyavsky, A., Amber, K.T., Agnoletti, A.F., Wang, C. and Grando, S.A. (2019) Synergy among Non-Desmoglein Antibodies Contributes to the Immunopathology of Desmoglein Antibody-Negative Pemphigus Vulgaris. Journal of Biological Chemistry, 294, 4520-4528. [Google Scholar] [CrossRef] [PubMed]
[49] Hübner, F., Recke, A., Zillikens, D., Linder, R. and Schmidt, E. (2016) Prevalence and Age Distribution of Pemphigus and Pemphigoid Diseases in Germany. Journal of Investigative Dermatology, 136, 2495-2498. [Google Scholar] [CrossRef] [PubMed]
[50] Ahmed, R., Al-Shaikh, S. and Akhtar, M. (2012) Hashimoto Thyroiditis. Advances in Anatomic Pathology, 19, 181-186. [Google Scholar] [CrossRef] [PubMed]
[51] González, D.A., Díaz, B.B., Rodríguez Pérez, M.D.C., Hernández, A.G., Chico, B.N.D. and de León, A.C. (2010) Sex Hormones and Autoimmunity. Immunology Letters, 133, 6-13. [Google Scholar] [CrossRef] [PubMed]
[52] Hu, X., Chen, Y., Shen, Y., Tian, R., Sheng, Y. and Que, H. (2022) Global Prevalence and Epidemiological Trends of Hashimoto’s Thyroiditis in Adults: A Systematic Review and Meta-Analysis. Frontiers in Public Health, 10, Article 1020709. [Google Scholar] [CrossRef] [PubMed]
[53] Joly, P., Maho-Vaillant, M., Prost-Squarcioni, C., Hebert, V., Houivet, E., Calbo, S., et al. (2017) First-Line Rituximab Combined with Short-Term Prednisone versus Prednisone Alone for the Treatment of Pemphigus (Ritux 3): A Prospective, Multicentre, Parallel-Group, Open-Label Randomised Trial. The Lancet, 389, 2031-2040. [Google Scholar] [CrossRef] [PubMed]
[54] Tedbirt, B., Maho-Vaillant, M., Houivet, E., Mignard, C., Golinski, M., Calbo, S., et al. (2024) Sustained Remission without Corticosteroids among Patients with Pemphigus Who Had Rituximab as First-Line Therapy. JAMA Dermatology, 160, 290-296. [Google Scholar] [CrossRef] [PubMed]
[55] El Fassi, D., Nielsen, C.H., Bonnema, S.J., Hasselbalch, H.C. and Hegedüs, L. (2007) B Lymphocyte Depletion with the Monoclonal Antibody Rituximab in Graves’ Disease: A Controlled Pilot Study. The Journal of Clinical Endocrinology & Metabolism, 92, 1769-1772. [Google Scholar] [CrossRef] [PubMed]
[56] Salvi, M., Vannucchi, G., Currò, N., Campi, I., Covelli, D., Dazzi, D., et al. (2015) Efficacy of B-Cell Targeted Therapy with Rituximab in Patients with Active Moderate to Severe Graves’ Orbitopathy: A Randomized Controlled Study. The Journal of Clinical Endocrinology & Metabolism, 100, 422-431. [Google Scholar] [CrossRef] [PubMed]
[57] Kahara, T., Iwaki, N., Kaya, H., Kurokawa, T., Yoshida, T., Ishikura, K., et al. (2011) Transition of Thyroid Autoantibodies by Rituximab Treatment for Thyroid MALT Lymphoma. Endocrine Journal, 58, 7-12. [Google Scholar] [CrossRef] [PubMed]
[58] Haugen, B.R. (2009) Drugs That Suppress TSH or Cause Central Hypothyroidism. Best Practice & Research Clinical Endocrinology & Metabolism, 23, 793-800. [Google Scholar] [CrossRef] [PubMed]
[59] Al-Bahadili, H., Powers Carson, J., Markov, A. and Jasim, S. (2025) The Complex Web of Interferences with Thyroid Function Tests. Endocrine Practice, 31, 92-101. [Google Scholar] [CrossRef] [PubMed]